Amrize Ltd
NYSE:AMRZConstruction Materials
+$1.05 today
- Market cap
- $22.10B
- Beta
- -0.09
Volume 3.68M
Average 3.11M
AMRZ Sales of Investments
Cash received from selling or redeeming investments.
Amrize LtdNYSE: AMRZ
Sales of Investments · Q2 FY2026 · quarter ended Jun 2026
Sales of investments outflow grows to $0
Q2 FY2026 sales of investments was $0, compared with $0 a year earlier. Trailing-twelve-month sales of investments was $0.
Context
- Sales of investments amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
- Sales of investments increased in 0 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly sales of investments holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.
Sources:Cash FlowText generated from reported figures; not investment advice.
Sales of Investments history
USD · from the cash flow
- Latest · FY2025
- 0 USD
- Year-over-year change
- —
| Period | Period end | Sales of Investments | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | — |
| FY2024 | 2024-12-31 | 0 | — |
| FY2023 | 2023-12-31 | 0 | — |
| FY2022 | 2022-12-31 | 0 | — |
| FY2021 | 2021-12-31 | 0 | — |
Sales of Investments vs competitors
How AMRZ compares with its peers on the latest reported figures
- AMRZ's LTM Jun 2026 sales of investments of $0 is the 2nd largest of the 7 companies compared; the peer median is $0.
- Sales of investments amounts to 0.0% of revenue for AMRZ, versus a peer median of 0.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $17M | — | — | 0.3% | |
AMRZAmrize Ltd | LTM Jun 2026 | $0 | — | — | 0.0% |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| LTM Jun 2026 | $0 | -100.0% | — | 0.0% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding AMRZ) | $0 | -100.0% | — | 0.0% | |
Competitors are the stored peer set for AMRZ. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 843M | 1.11B | 955M | 1.27B | 1.19B |
| Depreciation & Amortization | 712M | 788M | 851M | 875M | 914M |
| Deferred Income Tax | 105M | 66M | 11M | (35M) | 78M |
| Stock-Based Compensation | 4M | 4M | 5M | 6M | 0 |
| Change in Working Capital | (98M) | 14M | 117M | 38M | (126M) |
| Accounts Receivables | (38M) | 35M | (82M) | 189M | 6M |
| Inventory | (41M) | (296M) | (7M) | (146M) | (61M) |
| Accounts Payables | 154M | 195M | 60M | 28M | 108M |
| Other Working Capital | (173M) | 80M | 146M | (33M) | (179M) |
| Other Non-Cash Items | (74M) | 9M | 97M | 125M | 157M |
| Operating Cash Flow | 1.49B | 1.99B | 2.04B | 2.28B | 2.21B |
| Capital Expenditures | (394M) | (488M) | (630M) | (642M) | (788M) |
| Acquisitions (Net) | (3.45B) | (1.98B) | (1.61B) | (249M) | (86M) |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 1.35B | (52M) | 212M | (317M) | 513M |
| Investing Cash Flow | (2.5B) | (2.52B) | (2.03B) | (1.21B) | (361M) |
| Debt Repayment | 761M | 725M | 747M | (225M) | (1.44B) |
| Common Stock Issued | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 475M | (228M) | (13M) | (312M) | (118M) |
| Financing Cash Flow | 1.24B | 497M | 734M | (537M) | (1.56B) |
| Effect of Forex Changes | (4M) | (12M) | 11M | (59M) | 45M |
| Net Change in Cash | 226M | (48M) | 756M | 478M | 337M |
| Free Cash Flow | 1.1B | 1.5B | 1.41B | 1.64B | 1.42B |
Amrize Ltd
NYSE:AMRZ
Intrinsic Alpha fair value
Locked
Current Price
$40.41
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.